LCN2 and endometrial carcinoma: An LCM-microarray study showed that the LCN2 expression was upregulated during the malignant process of endometrial carcinoma, and the forced expression of LCN2 promoted cell growth and increased the invasive potential of endometrial carcinoma cells.